Clinical Trial Update: Controlled Attenuation Parameter (CAP) in Liver Allografts

View source ↗

Summary

A completed clinical trial examining the use of controlled attenuation parameter (CAP) to assess liver allografts in liver transplant patients, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Dysfunction
• Liver Disease
• Liver Steatosis
• Liver Transplant
• Non-function

Snippet

Sponsor: Andres Duarte-Rojo | Conditions: Liver Transplant, Liver Steatosis | Status: COMPLETED | Results posted: 2020-07-31